Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


J Am Soc Nephrol 17: 291-295, 2006
© 2006 American Society of Nephrology
doi: 10.1681/ASN.2006080929
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rodrigo, E.
Right arrow Articles by Arias, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodrigo, E.
Right arrow Articles by Arias, M.

Supplement Articles

New-Onset Diabetes after Kidney Transplantation: Risk Factors

Emilio Rodrigo, Gema Fernández-Fresnedo, Rosalía Valero, Juan Carlos Ruiz, Celestino Piñera, Rosa Palomar, Julio González-Cotorruelo, Carlos Gómez-Alamillo and Manuel Arias

Nephrology Service, University of Cantabria, Santander, Spain

Address correspondence to: Dr. Manuel Arias, Nephrology service, University of Cantabria, Avda. Valdecilla s/n 39008, Santander, Spain. Phone: +34942202738; Fax: +34942320415; E-mail: nefarm{at}humv.es

New-onset diabetes after transplantation (NODAT) contributes to the risk for cardiovascular disease and infection, reducing graft and patient survival. For improvement of the outcome of kidney transplant recipients, it is of great interest to know precisely the risk factors that contribute to NODAT development. Nonmodifiable risk factors for development of NODAT are age, race, genetic background, family history of diabetes, and previous glucose intolerance. Modifiable risk factors are obesity and overweight, hepatitis C virus and cytomegalovirus infections, and immunosuppressive drugs. Both steroids and calcineurin inhibitors influence the appearance of NODAT, whereas the role of sirolimus in glucose metabolism currently is controversial.




This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
D. R. J. Kuypers, K. Claes, B. Bammens, P. Evenepoel, and Y. Vanrenterghem
Early clinical assessment of glucose metabolism in renal allograft recipients: diagnosis and prediction of post-transplant diabetes mellitus (PTDM)
Nephrol. Dial. Transplant., June 1, 2008; 23(6): 2033 - 2042.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
E. S. Kang, M. S. Kim, Y. S. Kim, C. H. Kim, S. J. Han, S. W. Chun, K. Y. Hur, C. M. Nam, C. W. Ahn, B. S. Cha, et al.
A Polymorphism in the Zinc Transporter Gene SLC30A8 Confers Resistance Against Posttransplantation Diabetes Mellitus in Renal Allograft Recipients
Diabetes, April 1, 2008; 57(4): 1043 - 1047.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
D. L. Segev, C. E. Simpkins, R. E. Thompson, J. E. Locke, D. S. Warren, and R. A. Montgomery
Obesity Impacts Access to Kidney Transplantation
J. Am. Soc. Nephrol., February 1, 2008; 19(2): 349 - 355.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
E. S. Kang, M. S. Kim, Y. S. Kim, K. Y. Hur, S. J. Han, C. M. Nam, C. W. Ahn, B. S. Cha, S. I. Kim, and H. C. Lee
A Variant of the Transcription Factor 7-Like 2 (TCF7L2) Gene and the Risk of Posttransplantation Diabetes Mellitus in Renal Allograft Recipients
Diabetes Care, January 1, 2008; 31(1): 63 - 68.
[Abstract] [Full Text] [PDF]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673